莱维体痴呆症
Zuzana Walker1, Katherine L Possin2, Bradley F Boeve3
1Division of Psychiatry, University College London, London, UK; North Essex Partnership University NHS Foundation Trust, Epping, UK.
Lancet (London, England)
|November 24, 2015
概括
莱维体痴呆症是老年人中第二常见的痴呆症, 最近的进展集中在改善诊断和开发针对潜在病理的治疗方法,以更好地管理患者.
科学领域:
- 神经学
- 神经科学
- 老年病学
背景情况:
- 痴呆症是一个重要的全球健康问题,阿尔茨海默病得到了大量研究重点.
- 列维体痴呆症 (LBD),包括列维体痴呆症和帕金森病痴呆症,是65岁以上人群中发病率第二高的退行性痴呆症.
- 尽管LBD的发病率很高,但患者的诊断和治疗常常不足.
研究的目的:
- 审查最近在莱维体痴呆症的诊断和理解方面的进展.
- 突出开发有效治疗LBD的挑战和未来方向.
- 强调需要提高诊断准确性和针对性治疗.
主要方法:
- 对过去10年的相关科学文献进行审查.
- 对LBD诊断标准的改进情况的分析.
- 对成像和生物标志物在LBD诊断中的作用的评估.
主要成果:
- 为了提高LBD的诊断准确性,已经做出了重大努力.
- 莱维体痴呆症和帕金森病痴呆症之间存在共享的病理生理学.
- 在识别诊断标志物和了解疾病机制方面取得了进展.
结论:
- 改善诊断精度和生物标志物开发对于LBD至关重要.
- 未来的治疗必须针对LBD的病理机制,最好是在症状前.
- 澄清病原性对于开发LBD疾病修饰疗法至关重要.
相关概念视频
Dementia
702
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
702
Parkinson's Disease: Overview
2.4K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.4K
Alzheimer's Disease: Overview
2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Neural Regulation
44.8K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
44.8K
Lysosomal Hydrolases
4.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.7K
Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K


